Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation

被引:177
作者
Arakawa, R
Yokoyama, S
机构
[1] Nagoya City Univ, Grad Sch Med Sci, Dept Biochem Cell Biol & Metab, Mizuho Ku, Nagoya, Aichi 4678601, Japan
[2] Grelan Pharmaceut Co Ltd, Div Res & Dev, Tokyo 2050002, Japan
关键词
D O I
10.1074/jbc.M202996200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP-binding cassette transporter (ABC) A1 was increased by apolipoprotein A-I without an increase of its message in THP-1 cells. The pulse label study demonstrated that apoA-I retarded degradation of ABCA1. Similar changes were demonstrated by apoA-II, but the effect of high density lipoprotein was almost negligible on the basis of equivalent protein concentration. Thiol protease inhibitors (leupeptin and N-acetyl-Leu-Leu-norleucinal (ALLN)) increased ABCA1 and slowed its decay in the cells, whereas none of the proteosome-specific inhibitor lactacystin, other protease inhibitors, or the lysosomal inhibitor NH4Cl showed such effects. The effects of apoA-I and ALLN were additive for the increase of ABC.,U,, and the apoA-I-mediated cellular lipid release was enhanced by ALLN. The data suggest that ABCA1 is rapidly degraded by a thiol protease(s) in the cells unless helical apolipoproteins in their lipid-free form stabilize ABCA1 by protecting it from protease-mediated degradation.
引用
收藏
页码:22426 / 22429
页数:4
相关论文
共 31 条
  • [1] Characterization of apolipoprotein-mediated HDL generation induced by cAMP in a murine macrophage cell line
    Abe-Dohmae, S
    Suzuki, S
    Wada, Y
    Aburatani, H
    Vance, DE
    Yokoyama, S
    [J]. BIOCHEMISTRY, 2000, 39 (36) : 11092 - 11099
  • [2] Arakawa R, 2000, J LIPID RES, V41, P1952
  • [3] BIELICKI JK, 1992, J LIPID RES, V33, P1699
  • [4] The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
    Bodzioch, M
    Orsó, E
    Klucken, T
    Langmann, T
    Böttcher, L
    Diederich, W
    Drobnik, W
    Barlage, S
    Büchler, C
    Porsch-Özcürümez, M
    Kaminski, WE
    Hahmann, HW
    Oette, K
    Rothe, G
    Aslanidis, C
    Lackner, KJ
    Schmitz, G
    [J]. NATURE GENETICS, 1999, 22 (04) : 347 - 351
  • [5] Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
    Brooks-Wilson, A
    Marcil, M
    Clee, SM
    Zhang, LH
    Roomp, K
    van Dam, M
    Yu, L
    Brewer, C
    Collins, JA
    Molhuizen, HOF
    Loubser, O
    Ouelette, BFF
    Fichter, K
    Ashbourne-Excoffon, KJD
    Sensen, CW
    Scherer, S
    Mott, S
    Denis, M
    Martindale, D
    Frohlich, J
    Morgan, K
    Koop, B
    Pimstone, S
    Kastelein, JJP
    Genest, J
    Hayden, MR
    [J]. NATURE GENETICS, 1999, 22 (04) : 336 - 345
  • [6] Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transporter
    Chambenoit, O
    Hamon, Y
    Marguet, D
    Rigneault, H
    Rosseneu, M
    Chimini, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (13) : 9955 - 9960
  • [7] COOLICAN SA, 1984, J BIOL CHEM, V259, P1627
  • [8] Costet P, 2000, J BIOL CHEM, V275, P28240
  • [9] INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN
    FENTEANY, G
    STANDAERT, RF
    LANE, WS
    CHOI, S
    COREY, EJ
    SCHREIBER, SL
    [J]. SCIENCE, 1995, 268 (5211) : 726 - 731
  • [10] DEFECTIVE REMOVAL OF CELLULAR CHOLESTEROL AND PHOSPHOLIPIDS BY APOLIPOPROTEIN-A-I IN TANGIER DISEASE
    FRANCIS, GA
    KNOPP, RH
    ORAM, JF
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (01) : 78 - 87